Arslan, M.; Novak, M.; Rosenthal, D.; Hartmann, C.J.; Albrecht, P.; Samadzadeh, S.; Hefter, H.
Cholinesterase Deficiency Syndrome—A Pitfall in the Use of Butyrylcholinesterase as a Biomarker for Wilson’s Disease. Biomolecules 2022, 12, 1398.
https://doi.org/10.3390/biom12101398
AMA Style
Arslan M, Novak M, Rosenthal D, Hartmann CJ, Albrecht P, Samadzadeh S, Hefter H.
Cholinesterase Deficiency Syndrome—A Pitfall in the Use of Butyrylcholinesterase as a Biomarker for Wilson’s Disease. Biomolecules. 2022; 12(10):1398.
https://doi.org/10.3390/biom12101398
Chicago/Turabian Style
Arslan, Max, Max Novak, Dietmar Rosenthal, Christian J. Hartmann, Philipp Albrecht, Sara Samadzadeh, and Harald Hefter.
2022. "Cholinesterase Deficiency Syndrome—A Pitfall in the Use of Butyrylcholinesterase as a Biomarker for Wilson’s Disease" Biomolecules 12, no. 10: 1398.
https://doi.org/10.3390/biom12101398
APA Style
Arslan, M., Novak, M., Rosenthal, D., Hartmann, C. J., Albrecht, P., Samadzadeh, S., & Hefter, H.
(2022). Cholinesterase Deficiency Syndrome—A Pitfall in the Use of Butyrylcholinesterase as a Biomarker for Wilson’s Disease. Biomolecules, 12(10), 1398.
https://doi.org/10.3390/biom12101398
